Psoriasis: response to high‐dose intravenous immunoglobulin in three patients

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Dermatology

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2133.2002.04753.xPMID 12207600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

  2001cited by this paper
• Treatment of psoriatic arthritis with antitumour necrosis factor‐α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

  2001cited by this paper
• British Association of Dermatologists

  2001cited by this paper
• The treatment of atopic dermatitis with adjunctive high‐dose intravenous immunoglobulin: a report of three patients and review of the literature

  2000cited by this paper
• Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

  2000cited by this paper
• Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).

  2000cited by this paper
• Recent developments in the understanding of the pathogenesis of psoriasis

  1999cited by this paper
• Adverse Effects of Intravenous Immunoglobulin Therapy

  1999cited by this paper
• Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

  1999cited by this paper
• Dermatological uses of high-dose intravenous immunoglobulin.

  1998cited by this paper
• Intravenous immunoglobulin in autoimmune chronic urticaria

  1998cited by this paper
• Mechanisms of action of intravenous immune globulin in immune‐mediated diseases

  1996cited by this paper
• Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy

  1996cited by this paper
• The viral safety of intravenous immune globulin

  1996cited by this paper
• The cutaneous features of tuberous sclerosis: a population study

  1996cited by this paper
• Aetiology and pathogenesis of psoriasis

  1996cited by this paper
• High‐dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris

  1995cited by this paper
• Immunopathogenesis and immunotherapy of psoriasis.

  1995cited by this paper
• Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins

  1995cited by this paper
• Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.

  1994cited by this paper
• British National Formulary

  1994cited by this paper
• Requirements for safety and quality of intravenous immunoglobulin G preparations.

  1994cited by this paper
• Juvenile dermatomyositis: treatment with intravenous gammaglobulin

  1994cited by this paper
• Epidemiology of psoriasis: clinical issues.

  1994cited by this paper
• Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

  1994cited by this paper
• A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

  1993cited by this paper
• Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.

  1993cited by this paper
• Adverse Effects of Intravenous Immunoglobulin

  1993cited by this paper
• The skin immune system: progress in cutaneous biology.

  1993cited by this paper
• Keratinocytes as initiators of inflammation.

  1991cited by this paper
• Treatment of dermatomyositis with intravenous gammaglobulin.

  1991cited by this paper
• Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

  1991cited by this paper
• Psoriatic arthritis in psoriatic patients.

  1984cited by this paper
• Treatment of psoriasis.

  1976cited by this paper
• Psoriatic arthritis.

  1973cited by this paper
• PSORIATIC ARTHRITIS.

  1965cited by this paper
• Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

  1946cited by this paper
• Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

  1946cited by this paper
• Treatment of Psoriasis

  1873cited by this paper

• Pediatric Pustular Psoriasis in Southern China: A 12-Year Retrospective Analysis of 41 Cases Focusing on Clinical Characteristics and Treatment Outcomes

  2025cites this paper
• FcγRIIB inhibits inflammation in a murine model of psoriasis.

  2022cites this paper
• Immunotherapy using Histobulin™ in psoriasis: A case report

  2022cites this paper
• Intravenous Immunoglobulin Therapy

  2021cites this paper
• Immunotherapy Using HistobulinTM In Psoriasis: A Case Report

  2021cites this paper
• Unconventional treatment options in psoriasis: A review.

  2021cites this paper
• Multi-omics study in monozygotic twins confirm the contribution of de novo mutation to psoriasis.

  2019cites this paper
• Consenso Mexicano para la prescripción de inmunoglobulina G como tratamiento de reemplazo e inmunomodulación

  2018cites this paper
• The Whiplash Rash

  2017cites this paper
• Treatment of selective antibody deficiency with IVIG resulting in decreased frequency of streptococcal infection and improvement of guttate psoriasis.

  2017cites this paper
• Psoriasis: An Unusual Autoimmune Manifestation in a Boy with Common Variable Immunodeficiency

  2017cites this paper
• Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy

  2016cites this paper
• Effect of Adalimumab on Gene Expression Profiles of Psoriatic Skin and Blood.

  2016cites this paper
• Off-Label Dermatological Uses of Intravenous Immunoglobulin Treatment

  2015cites this paper
• Inequality in the distribution of rheumatologists in Brazil: correlation with local of medical residency, Gross Domestic Product and Human Development Index.

  2014cites this paper
• S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3.

  2013cites this paper
• Myelin-associated glycoprotein-related neuropathy associated with psoriasis: a case report

  2013cites this paper
• A New Kid on the Block: IL-10+ Regulatory B Cells and a Possible Role In Psoriasis.

  2012cites this paper
• Immunomodulatory Effects of Intravenous Immunoglobulins (IVIGs) in HIV-1 Disease: A Systematic Review

  2011cites this paper
• Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.

  2009cites this paper
• Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

  2009cites this paper
• Streptococcus sp. and Staphylococcus aureus Isolates from Patients with Psoriasis Possess Genes That Code for Toxins (Superantigens): Clinical and Therapeutic Implications

  2008cites this paper
• The use of i.v. IG therapy in dermatology

  2007cites this paper
• Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action

  2007cites this paper
• Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).

  2007cites this paper
• Off-label uses of biologic agents in dermatology: a 2006 update.

  2006cites this paper
• Canadian Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in Dermatology

  2006cites this paper
• A Case of Dyshidrotic Eczema Developing after High-dose Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  2006cites this paper
• Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.

  2006cites this paper
• Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

  2006cites this paper
• Psoriasis improved by intravenous immunoglobulin therapy.

  2006cites this paper
• Clinical uses of intravenous immunoglobulin

  2005cites this paper
• Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience.

  2005cites this paper
• Efficacy and Safety of Intravenous Immunoglobulin for Immune-Mediated Skin Disease

  2004cites this paper
• Inmunoglobulina intravenosa en dermatosis infantiles

  2004cites this paper
• Therapeutic Manipulation of the Complement System in Dermatology

  2004cites this paper
• The development of asthma in patients with allergic rhinitis Review: (pp 159–164)

  2003cites this paper
• Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies

  2003cites this paper